The Role of Chelation in the Treatment of Arsenic and Mercury Poisoning

Journal of Medical Toxicology

Volumn 9, Issue 4, 2013, Pages 347-354

  Kosnett, Michael J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Chelating agents; Dimercaprol; Mercury; Succimer; Unithiol

Indexed keywords

ARACHIS OIL; DIMERCAPROL; MERCURIC CHLORIDE; NEOARSPHENAMINE; PENICILLAMINE; PHENYLMERCURIC ACETATE; SUCCIMER; UNITHIOL;

ARSENIC POISONING; ARTICLE; CHELATION THERAPY; COGNITIVE DEFECT; DERMATITIS; DRUG EFFICACY; DRUG MEGADOSE; EXPOSURE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; INJECTION SITE PAIN; LACRIMATION DISORDER; LEUKOCYTE COUNT; LIVER TOXICITY; MERCURIALISM; NAUSEA AND VOMITING; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALIVATION DISORDER; SIDE EFFECT; SYPHILIS;

ANIMALS; ARSENIC POISONING; ARSENICALS; CHELATING AGENTS; CHELATION THERAPY; HUMANS; MERCURY POISONING; SUCCIMER; TREATMENT OUTCOME; UNITHIOL;

EID: 84889238846     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-013-0344-5     Document Type: Article

References (31)

1. Vilensky JA (2002) Dew of death: the story of Lewisite, America's World War I weapon of mass destruction. Indiana University Press, Bloomington.
2. Stocken LA, Thompson RHS (1946) British anti-lewisite. Dithiol compounds as antidotes for arsenic. Biochem J 40: 535-548.
3. Peters RA, Stocken LA, Thompson RHS (1945) British anti-lewisite (BAL). Nature 156: 616-619.
4. Chiesman WE (1944) Diagnosis and treatment of lesions due to vesicants. Br Med J 2(4359): 109-112.
5. Luetscher JA, Eagle H, Longcope WT, Watson EB (1946) Clinical uses of 2, 3-dimercaptopropanol (BAL). VIII. The effect of BAL on the excretion of arsenic in arsenical intoxication. J Clin Investig 25(4): 534-540.
6. Carleton AB, Peters RA, Thompson RHS (1948) The treatment of arsenical dermatitis with dimercaptopropanol (BAL). Q J Med 17: 49-79.
7. Woody NC, Kometani JT (1948) BAL in the treatment of arsenic ingestion of children. Pediatrics 1(3): 372-378.
8. Petrunkin VE (1956) Synthesis and properties of dimercapto derivatives of alkylsulfonic acids. Ukr Khem Zh 22: 603-607.
9. Liang Y, Chu C, Tsen Y, Ting K (1957) Studies on antibilharzial drugs. VI. The antidotal effects of sodium dimercaptosuccinate and BAL-glucoside against tartar emetic. Acta Physiol Sin 21: 24-32.
10. Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E (1984) DMSA, DMPS, and DMPA-as arsenic antidotes. Fundam Appl Toxicol 4: S58-S70.
11. Eagle H, Magnuson HJ, Fleischman R (1946) Clinical uses of 2, 3 dimercaptopropanol (BAL). I. The systemic treatment of experimental arsenic poisoning (marphasen, lewisite, phenyl arsenoxide) with BAL. J Clin Investig 25: 451-466.
12. Tadlock CH, Aposhian HV (1980) Protection of mice against the lethal effects of sodium arsenite by 2, 3-dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid. Biochem Biophys Res Commun 94: 501-507.
13. Guha Mazumder DN, De BK, Santra A, Ghosh N, Das S, Lahiri S, Das T (2001) Randomized placebo-controlled trial of 2, 3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. Clin Toxicol 39: 665-674.
14. Guha Mazumder DN, Ghoshal UC, Saha J, Santra A, De BK, Chatterjee A et al (1998) Randomized placebo-controlled trial of 2, 3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water. Clin Toxicol 36: 683-690.
15. Nickle RA (1999) Mercury-top of the hit parade for eight years. Drug Chem Toxicol 22(1): 129-142.
16. Longcope WT, Luetscher JA (1949) The use of BAL (British Anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury, and other metallic poisons. Ann Intern Med 31: 545-553.
17. Nielsen JB, Andersen O (1991) Effect of four thiol-containing chelators on disposition of orally administered mercuric chloride. Hum Exp Toxicol 10: 423-430.
18. Wannag A, Aaseth A (1980) The effect of immediate and delayed treatment with 2, 3-dimercapto-propane-1-sulphonate on the distribution and toxicity of inorganic mercury in mice and in foetal and adult rats. Acta Pharmacol Toxicol 46: 81-88.
19. Planas-Bohne F (1977) The excretion of two renal enzymes as influenced by mercuric chloride and DMPS. In: Brown SS (ed) Clinical chemistry and chemical toxicology of metals. Elsevier, New York, pp 119-122.
20. Planas-Bohne F (1981) The effect of 2, 3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the distribution and excretion of mercuric chloride in rats. Toxicology 18: 275-278.
21. Treatment of Lead-Exposed Children (TLC) Trial Group (2000) Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 Microg/dL. Pediatr Res 48(5): 593-599.
22. Smith DR. The scientific basis for chelation: animal studies and lead chelation. J Med Toxicol 2013;9(4). doi: 10. 1007/s13181-013-0339-2.
23. Berlin M, Rylander R (1964) Increased brain uptake of mercury induced by 2, 3-dimercaptopropanol (BAL) in mice exposed to phenylmercuric acetate. J Pharmacol Exp Ther 146: 236-240.
24. Cichini GM, Petzl DH, Zeitlhofer J, Wolf C, Meisinger V, Strasser K et al (1989) Effekt von DMPS und d-Penicillamin bei inhalativer Intoxikation mit metallischem Quecksilber. Intensivmed Notf Med 26(6): 303-306.
25. Buchet JP, Lauwerys RR (1989) Influence of 2, 3 dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Toxicology 54: 323-333.
26. Nerudová J, Cábelková Z, Frantík E, Lukás E, Urban P, Bláha K et al (2000) Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden. Int J Occup Med Environ Health 13: 131-146.
27. Aposhian HV, Morgan DL, Queen HLS, Maiorino RM, Aposhian MM (2003) Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor. Clin Toxicol 41: 339-347.
28. Bridges CC, Joshee L, Zalups RK (2008) Multi-drug resistance proteins and the renal elimination of inorganic mercury mediated by 2, 3-dimercaptopropane-1-sulfonic acid and meso-2, 3-dimercaptosuccinic acid. J Pharmacol Exp Ther 324: 383-390.
29. Zalups RK, Bridges CC (2012) Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury. Chem Res Toxicol 25: 1825-1838.
30. Roels HA, Boeck M, Ceulemans E, Lauwerys RR (1991) Urinary excretion of mercury after occupational exposure to mecury vapour and influence of the chelating agent meso-2, 3-dimercaptosuccinic acid (DMSA). Brit J Ind Med 48: 247-253.
31. Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV (1998) DMPS (2, 3-dimercaptopropane-1-sulfonate, Dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther 287: 8-12.